INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 65 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $46,000 | +17.9% | 39,300 | +113.4% | 0.02% | +280.0% |
Q1 2018 | $39,000 | -75.3% | 18,418 | -76.3% | 0.01% | -73.7% |
Q4 2017 | $158,000 | +163.3% | 77,665 | +73.4% | 0.02% | +26.7% |
Q2 2016 | $60,000 | -27.7% | 44,800 | +322.8% | 0.02% | -70.0% |
Q4 2015 | $83,000 | – | 10,597 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |